Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
3 Tampilan
• 08/04/23
0
0
Menanamkan
administrator
Pelanggan
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru